AHA applauds 21st Century Cures but wants more

The draft proposal from House Energy and Commerce Committee--the 21st Century Cures initiative, released Jan. 27--includes telehealth policies but the American Hospital Association (AHA) is pushing for more.

AHA "strongly agrees with your goal of expanding coverage of telehealth services in Medicare," according to a letter sent to committee chairman Rep. Fred Upton (R-Mich.), referring to the proposal for the Department of Health and Human Services (HHS) to create a methodology that would expand coverage and payment for telehealth services.

However, AHA disagrees with the part of the proposal that says it only applies if the Centers for Medicare & Medicaid Services finds that the services "would reduce [or would not result in any increase in] net program spending under this title."

The proposal does not address technology limitations in the Medicare program or how remote monitoring will be paid for, according to the AHA. "We also are concerned that the requirement for the Medicare actuary to certify telehealth cost neutrality for specific services would be hard for HHS to operationalize, and would add a time-consuming step when technology is advancing at a rapid pace."

AHA's own recent Trend Watch report identified lower costs and improved care through the use of telemedicine.

AHA says it agrees with the "goal of expanding coverage of telehealth services in Medicare, and appreciates the specification of a mechanism for doing so," but says a more global approach is needed.  

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.